Stock(600222)Hot line:010-61006450

CMC

Committed to the development and innovation of first-class drugs

API R&D Platform

There are more than 100 R&D personnel in the API division, committed to building a first-class API platform with multiple functions including R&D, registration, production and sales. The platform brings together many experts in synthesis, production, quality and registration. It can quickly synthesize complex compounds and complete targeted research on impurities. At the same time, it focuses on industrial transformation and green chemistry, and can provide customers with raw materials and intermediates ranging from milligrams to kilograms.

 

The company established an API industrial base in Miyun, covering an area of nearly 2000 square meters, which can meet the production and preparation of laboratory products ranging from 100 grams to kilograms.